Chemours
503 hedge funds and large institutions have $3.94B invested in Chemours in 2021 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 145 increasing their positions, 137 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% more repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 137
1.77% less ownership
Funds ownership: 74.01% → 72.24% (-1.8%)
49% less call options, than puts
Call options by funds: $49.8M | Put options by funds: $98.5M
Holders
503
Holding in Top 10
8
Calls
$49.8M
Puts
$98.5M
Top Buyers
| 1 | +$58.3M | |
| 2 | +$19.8M | |
| 3 | +$18.2M | |
| 4 |
Goldman Sachs
New York
|
+$13.7M |
| 5 |
D.E. Shaw & Co
New York
|
+$11.4M |
Top Sellers
| 1 | -$69.9M | |
| 2 | -$37.4M | |
| 3 | -$35.7M | |
| 4 |
SC
Sessa Capital
New York
|
-$22.9M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$21.1M |